Physician Assistant · Omaha, NE
NPI
1346512597
Since 2012
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
601 N 30th St, #5730
Omaha, NE, 68131
Phone (402) 449-4692
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,047
90 services
Medicare patients, 2024
72
Average age 73
Drug cost, 2024
$1.2M
461 prescriptions
Company payments, 2025
$210
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tara K Hunke was code 99213 (office e&m - established), 29 times for 29 patients. In total Tara K Hunke billed 90 services in 12 codes, and Medicare paid $5,047.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 29 | 29 | $42.42 | $1,230 |
| 99214 Office E&M - Established | Office | 28 | 26 | $73.35 | $2,054 |
| 99203 Office E&M - New | Office | 14 | 14 | $63.99 | $896 |
By year: 2022 $4,744 for 89 services; 2023 $4,047 for 73 services; 2024 $5,047 for 90 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tara K Hunke prescribed most often to Medicare patients was Omeprazole, with 116 prescriptions and refills. In total Tara K Hunke wrote 461 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 116 | 206 | 34 | $1,720 |
| Stelara Ustekinumab | 31 | 40 | Under 11 | $840K |
| Mesalamine Generic | 26 | 62 | Under 11 | $23K |
| Linzess Linaclotide | 21 | 32 | Under 11 | $18K |
| Pantoprazole Sodium Generic | 21 | 33 | Under 11 | $92.5 |
| Motegrity Prucalopride Succinate | 20 | 28 | Under 11 | $15K |
| Nortriptyline Hcl Generic | 18 | 38 | Under 11 | $493 |
| Budesonide Ec Budesonide | 15 | 21 | Under 11 | $5,355 |
| Famotidine Generic | 14 | 20 | Under 11 | $60.53 |
| Ondansetron Odt Ondansetron | 14 | 14 | Under 11 | $225 |
| Mesalamine Mesalamine W/Cleansing Wipes | 13 | 13 | Under 11 | $2,819 |
| Dicyclomine Hcl Generic | 12 | 24 | Under 11 | $300 |
| Creon Lipase/Protease/Amylase | 12 | 12 | Under 11 | $16K |
Brand drugs: 132 claims; generic drugs: 329 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tara K Hunke $210 ($210 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $47.2.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 3 | $47.2 |
| Pharmacosmos Therapeutics Inc. | 2 | $42.85 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $22.84 |
| Eisai Inc. 4523.T | 1 | $20.49 |
| Puma Biotechnology, Inc. PBYI | 1 | $16.39 |
| Avyxa Pharma, LLC | 1 | $15.51 |
| Gilead Sciences, Inc. GILD | 1 | $15.03 |
| Octapharma USA, Inc. | 1 | $14.92 |
| Agios Pharmaceuticals, Inc. AGIO | 1 | $14.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.